These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11407356)

  • 1. Aspiration pneumonia.
    Dreyfuss D; Mier L
    N Engl J Med; 2001 Jun; 344(24):1868-9; author reply 1869-70. PubMed ID: 11407356
    [No Abstract]   [Full Text] [Related]  

  • 2. Is penicillin G an adequate initial treatment for aspiration pneumonia? A prospective evaluation using a protected specimen brush and quantitative cultures.
    Mier L; Dreyfuss D; Darchy B; Lanore JJ; Djedaïni K; Weber P; Brun P; Coste F
    Intensive Care Med; 1993; 19(5):279-84. PubMed ID: 8408937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspiration pneumonia.
    Japanese Respiratory Society
    Respirology; 2009 Nov; 14 Suppl 2():S59-64. PubMed ID: 19857224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effects and bronchoalveolar transfer of levofloxacin in patients with community-acquired pneumonia.
    Lin Y; Su W; Xu Z; Bai Y
    Chin Med J (Engl); 2001 Feb; 114(2):212-3. PubMed ID: 11780213
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of Pneumonia Syndromes in the Hospital: Make Pneumonia Your Best Friend.
    Kanal A; Sharpe BA; Abelson J
    Med Clin North Am; 2020 Jul; 104(4):587-599. PubMed ID: 32505254
    [No Abstract]   [Full Text] [Related]  

  • 6. Microbiology and drug resistance mechanisms of fully resistant pathogens.
    Walsh FM; Amyes SG
    Curr Opin Microbiol; 2004 Oct; 7(5):439-44. PubMed ID: 15451497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of levofloxacin-resistant pneumococci in immunocompromised adults after therapy for community-acquired pneumonia.
    Anderson KB; Tan JS; File TM; DiPersio JR; Willey BM; Low DE
    Clin Infect Dis; 2003 Aug; 37(3):376-81. PubMed ID: 12884162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of community-acquired pneumonia--treatment].
    Andersen LV; Brock B; Jakobsen P; Nielsen LP
    Ugeskr Laeger; 2008 Jan; 170(3):127-30. PubMed ID: 18208726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Microbiological diagnostic and antibiotic management of community aquired and nosocomial pneumonias in intensive care units in Germany].
    Meyer E; Ebner W; Heininger A; Schwab F; Rüden H; Daschner FD
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Feb; 40(2):85-90. PubMed ID: 15714398
    [No Abstract]   [Full Text] [Related]  

  • 10. [New quinolones for the treatment of community-acquired pneumonia--pro].
    Zimmerli S
    Dtsch Med Wochenschr; 2003 May; 128(19):1070. PubMed ID: 12736859
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical efficacy of newer agents in short-duration therapy for community-acquired pneumonia.
    File TM
    Clin Infect Dis; 2004 Sep; 39 Suppl 3():S159-64. PubMed ID: 15546111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspiration pneumonia. Recognizing and managing a potentially growing disorder.
    Johnson JL; Hirsch CS
    Postgrad Med; 2003 Mar; 113(3):99-102, 105-6, 111-2. PubMed ID: 12647477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New quinolones for the treatment of community-acquired pneumonia--contra].
    Egger M
    Dtsch Med Wochenschr; 2003 May; 128(19):1071. PubMed ID: 12736860
    [No Abstract]   [Full Text] [Related]  

  • 14. From the Food and Drug Administration.
    JAMA; 2000 Apr; 283(13):1679. PubMed ID: 10755481
    [No Abstract]   [Full Text] [Related]  

  • 15. [New quinolones].
    Bello Dronda S
    Arch Bronconeumol; 1999 May; 35 Suppl 3():70-6. PubMed ID: 10410229
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of aspiration pneumonia and primary lung abscess. Penicillin G vs clindamycin.
    Bartlett JG; Gorbach SL
    JAMA; 1975 Dec; 234(9):935-7. PubMed ID: 1041750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience in the management of community-acquired pneumonia: lessons from the use of fluoroquinolones.
    Carratalá J; Martín-Herrero JE; Mykietiuk A; García-Rey C
    Clin Microbiol Infect; 2006 May; 12 Suppl 3():2-11. PubMed ID: 16669924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aetiology and resistance patterns of community-acquired pneumonia in León, Nicaragua.
    Matute AJ; Brouwer WP; Hak E; Delgado E; Alonso E; Hoepelman IM
    Int J Antimicrob Agents; 2006 Nov; 28(5):423-7. PubMed ID: 17046211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility of Streptococcus pneumoniae isolated from patients with respiratory tract infections in Thailand.
    Srifuengfung S; Tribuddharat C; Champreeda P; Daniels J; Chokephaibulkit K; Wongwan N; Polwichai P
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):461-6. PubMed ID: 18564685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bacteremias of gastrointestinal origin].
    Cisterna Cancer R
    Rev Clin Esp; 1997 Dec; 197 Suppl 5():37-40. PubMed ID: 9558607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.